| 1. |
|
|
| 2. |
- Bernhardsson, Christian, et al.
(författare)
-
Environmental radiation baseline around the Belarusian nuclear power plant – assessments in Belarus and Lithuania
- 2023
-
Ingår i: Medical Physics in the Baltic States : Proceedings of the 16<sup>th</sup> International Conference on Medical Physics - Proceedings of the 16<sup>th</sup> International Conference on Medical Physics. - 1822-5721. ; , s. 121-125
-
Konferensbidrag (refereegranskat)abstract
- Prior to the operation of the first Belarussian nuclear power plant (BelNPP), the baseline of the radiation environment was determined within a radius of about 30 km from BelNPP. This independent assessment was carried out during two expeditions in 2019. In 2022, a similar survey was carried out (during the initialoperation of BelNPP) on the Lithuanian side of the boarder. Here we present the overall project and some general results of the baseline assessments.
|
|
| 3. |
|
|
| 4. |
- Chatzikonstantinou, T, et al.
(författare)
-
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
- 2021
-
Ingår i: Leukemia. - : Springer Science and Business Media LLC. - 1476-5551 .- 0887-6924. ; 35:12, s. 3444-3454
-
Tidskriftsartikel (refereegranskat)abstract
- Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to Coronavirus disease 2019 (COVID-19) due to age, disease, and treatment-related immunosuppression. We aimed to assess risk factors of outcome and elucidate the impact of CLL-directed treatments on the course of COVID-19. We conducted a retrospective, international study, collectively including 941 patients with CLL and confirmed COVID-19. Data from the beginning of the pandemic until March 16, 2021, were collected from 91 centers. The risk factors of case fatality rate (CFR), disease severity, and overall survival (OS) were investigated. OS analysis was restricted to patients with severe COVID-19 (definition: hospitalization with need of oxygen or admission into an intensive care unit). CFR in patients with severe COVID-19 was 38.4%. OS was inferior for patients in all treatment categories compared to untreated (p < 0.001). Untreated patients had a lower risk of death (HR = 0.54, 95% CI:0.41–0.72). The risk of death was higher for older patients and those suffering from cardiac failure (HR = 1.03, 95% CI:1.02–1.04; HR = 1.79, 95% CI:1.04–3.07, respectively). Age, CLL-directed treatment, and cardiac failure were significant risk factors of OS. Untreated patients had a better chance of survival than those on treatment or recently treated.
|
|
| 5. |
- Mansouri, L, et al.
(författare)
-
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
- 2023
-
Ingår i: Leukemia. - : Springer Science and Business Media LLC. - 1476-5551 .- 0887-6924. ; 37:2, s. 339-347
-
Tidskriftsartikel (refereegranskat)abstract
- Recent evidence suggests that the prognostic impact of gene mutations in patients with chronic lymphocytic leukemia (CLL) may differ depending on the immunoglobulin heavy variable (IGHV) gene somatic hypermutation (SHM) status. In this study, we assessed the impact of nine recurrently mutated genes (BIRC3, EGR2, MYD88, NFKBIE, NOTCH1, POT1, SF3B1, TP53, and XPO1) in pre-treatment samples from 4580 patients with CLL, using time-to-first-treatment (TTFT) as the primary end-point in relation to IGHV gene SHM status. Mutations were detected in 1588 (34.7%) patients at frequencies ranging from 2.3–9.8% with mutations in NOTCH1 being the most frequent. In both univariate and multivariate analyses, mutations in all genes except MYD88 were associated with a significantly shorter TTFT. In multivariate analysis of Binet stage A patients, performed separately for IGHV-mutated (M-CLL) and unmutated CLL (U-CLL), a different spectrum of gene alterations independently predicted short TTFT within the two subgroups. While SF3B1 and XPO1 mutations were independent prognostic variables in both U-CLL and M-CLL, TP53, BIRC3 and EGR2 aberrations were significant predictors only in U-CLL, and NOTCH1 and NFKBIE only in M-CLL. Our findings underscore the need for a compartmentalized approach to identify high-risk patients, particularly among M-CLL patients, with potential implications for stratified management.
|
|
| 6. |
|
|
| 7. |
- Andersson, Mike, et al.
(författare)
-
Investigations on the possibilities of a MISiCFET sensor system for OBD and combustion control utilizing different catalytic gate materials
- 2004
-
Ingår i: Topics in catalysis. - 1022-5528 .- 1572-9028. ; 30-31:1, s. 365-368
-
Tidskriftsartikel (refereegranskat)abstract
- Different catalytic materials, like Pt and Ir, applied as gate contacts on metal insulator silicon carbide field effect transistors — MISiCFET—facilitate the manufacture of gas sensor devices with differences in selectivity, devices which due to the chemical stability and wide band gap of SiC are suitable for high temperature applications. The combination of such devices in a sensor system, utilizing multivariate analysis/modeling, have been tested and some promising results in respect of monitoring a few typical exhaust and flue gas constituents, in the future aiming at on board diagnostics (OBD) and combustion control, have been obtained.
|
|
| 8. |
- Andersson, Mike, et al.
(författare)
-
On the applicability of MISiCFET gas sensors regarding ammonia slip monitoring in small-scale boilers running SNCR
- 2007
-
Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
- Gas sensitive Metal Insulator Silicon Carbide Field Effect Transistor – MISiCFET – devices have shown good possibilities of realizing sensors for high temperature applications. One such application could be the monitoring of ammonia slip from boilers running SNCR – Selective Non-Catalytic Reduction of nitrogen oxides (NOx) with ammonia (NH3). In this study a number of MISiCFET gas sensors operated at different temperatures and with both platinum (Pt) and iridium (Ir) as the gate contact have been tested for their ability to detect and quantify ammonia slip in flue gases from a 5.6 MW wood fired boiler during a test of a new SNCR-system. The individual sensors have been evaluated and compared to each other for the sensitivity towards NH3 and possible cross-sensitivities to other flue gas species through the comparison of the sensor signals with the signals from analytical instruments like FTIR – Fourier Transform Infrared spectroscopy – for nitrogen oxides (NO + NO2), NH3, and carbon monoxide (CO) and an FID – Flame Ionization Detector – for the Total Hydrocarbon Concentration (THC). The ability of a combination of sensors to provide extra or more accurate information about the NH3 concentration was also evaluated through the construction and validation of a Partial Least Squares – PLS – regression model based on all the sensor signals. Under the assumption that the sensors’ responses follow a logarithmic dependence on NH3 concentration the results regarding ammonia slip quantification were promising both for a single Ir sensor and for the system based on all sensors. There is still a question mark for the long-term stability of the devices in real flue gases, however.
|
|
| 9. |
- André, Alann, et al.
(författare)
-
Cirkulärt omhändertagande av solcellspaneler och vindturbinblad för vindkraftverk
- 2024
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- I regleringsbrevet för 2023 fick Energimyndigheten i uppdrag av regeringen att utreda hur solcellspaneler och vindturbinblad till vindkraftverk i högre utsträckning ska kunna tas om hand på ett giftfritt och cirkulärt sätt i enlighet med avfallshierarkin. Redovisningen av detta regeringsuppdrag, rapporten Från avfall till resurs – Förslag för en mer cirkulär hantering av solcellspaneler och vindturbinblad, ER 2024:11, baseras på denna underlagsrapport som har tagits fram av forskningsinstitutet RISE på uppdrag av Energimyndigheten. Analyser, slutsatser och förslag/rekommendationer som framförs i rapporten är författarnas egna.En fortsatt utbyggnad av fossilfri elproduktion är av stor vikt för att vi ska kunna nå Sveriges energi- och klimatmål. För att utbyggnaden i sig ska vara hållbar är det viktigt att vi redan nu planerar för hur avfallet från dessa elproduktionsanläggningar ska förebyggas, minimeras och sedan hanteras.Det finns redan i dagsläget aktörer som har utvecklat och håller på att utveckla ett flertal olika lösningar för ökad cirkularitet. Dessa möjligheter kan tas tillvara och främjas genom regelbunden kartläggning och genom att arbeta gemensamt inom EU. Genom ett sådant arbete finns det också större möjligheter att etablera industriella värdekedjor i Sverige för hanteringen av avfallet från solcellspaneler och vindturbinblad.En cirkulär hantering av avfall ger ett betydligt mindre avtryck på miljön än det som en linjär hantering ger upphov till. Det är viktigt att de aktörer som tillhandahåller fossilfri elproduktion tar ansvar under hela livscykeln och att det finns goda förutsättningar för aktörerna att göra det.
|
|
| 10. |
|
|
| 11. |
|
|
| 12. |
- Arruda, Lucas C. M., et al.
(författare)
-
A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells in vitro and in vivo
- 2022
-
Ingår i: Haematologica. - : Ferrata Storti Foundation (Haematologica). - 0390-6078 .- 1592-8721. ; 107:8, s. 1786-1795
-
Tidskriftsartikel (refereegranskat)abstract
- Less than a third of patients with acute myeloid leukemia (AML) are cured by chemotherapy and/or hematopoietic stem cell transplantation, highlighting the need to develop more efficient drugs. The low efficacy of standard treatments is associated with inadequate depletion of CD34(+) blasts and leukemic stem cells, the latter a drug-resistant subpopulation of leukemia cells characterized by the CD34(+)CD38(-) phenotype. To target these drug-resistant primitive leukemic cells better, we have designed a CD34/CD3 bi-specific T-cell engager (BTE) and characterized its anti-leukemia potential in vitro, ex vivo and in vivo. Our results show that this CD34-specific BTE induces CD34-dependent T-cell activation and subsequent leukemia cell killing in a dose-dependent manner, further corroborated by enhanced T-cell-mediated killing at the singlecell level. Additionally, the BTE triggered efficient T-cell-mediated depletion of CD34(+) hematopoietic stem cells from peripheral blood stem cell grafts and CD34(+) blasts from AML patients. Using a humanized AML xenograft model, we confirmed that the CD34-specific BTE had in vivo efficacy by depleting CD34(+) blasts and leukemic stem cells without side effects. Taken together, these data demonstrate that the CD34-specific BTE has robust antitumor effects, supporting development of a novel treatment modality with the aim of improving outcomes of patients with AML and myelodysplastic syndromes.
|
|
| 13. |
|
|
| 14. |
|
|
| 15. |
|
|
| 16. |
- Baliakas, Panagiotis, et al.
(författare)
-
Prognostic indices in chronic lymphocytic leukaemia : where do we stand how do we proceed?
- 2016
-
Ingår i: Journal of Internal Medicine. - : Wiley. - 0954-6820 .- 1365-2796. ; 279:4, s. 347-357
-
Forskningsöversikt (refereegranskat)abstract
- The remarkable clinical heterogeneity in chronic lymphocytic leukaemia (CLL) has highlighted the need for prognostic and predictive algorithms that can be employed in clinical practice to assist patient management and therapy decisions. Over the last 20 years, this research field has been rewarding and many novel prognostic factors have been identified, especially at the molecular genetic level. Whilst detection of recurrent cytogenetic aberrations and determination of the immunoglobulin heavy variable gene somatic hypermutation status have an established role in outcome prediction, next-generation sequencing has recently revealed novel mutated genes with clinical relevance (e.g. NOTCH1, SF3B1 and BIRC3). Efforts have been made to combine variables into prognostic indices; however, none has been universally adopted. Although a unifying model for all groups of patients and in all situations is appealing, this may prove difficult to attain. Alternatively, focused efforts on patient subgroups in the same clinical context and at certain clinically relevant 'decision points', that is at diagnosis and at initiation of first-line or subsequent treatments, may provide a more accurate approach. In this review, we discuss the advantages and disadvantages as well as the clinical applicability of three recently proposed prognostic models, the MD Anderson nomogram, the integrated cytogenetic and mutational model and the CLL-international prognostic index. We also consider future directions taking into account novel aspects of the disease, such as the tumour microenvironment and the dynamics of (sub)clonal evolution. These aspects are particularly relevant in view of the increasing number of new targeted therapies that have recently emerged.
|
|
| 17. |
|
|
| 18. |
- Baliakas, Panagiotis, 1977-, et al.
(författare)
-
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
- 2019
-
Ingår i: Haematologica. - : Ferrata Storti Foundation (Haematologica). - 1592-8721 .- 0390-6078. ; 104:2, s. 360-369
-
Tidskriftsartikel (refereegranskat)abstract
- Chronic lymphocytic leukemia (CLL) patients with differential somatic hypermutation status of the immunoglobulin heavy variable genes, namely mutated or unmutated, display fundamental clinico-biological differences. Considering this, we assessed prognosis separately within mutated (M-CLL) and unmutated (U-CLL) CLL in 3015 patients, hypothesizing that the relative significance of relevant indicators may differ between these two categories. Within Binet A M-CLL patients, besides TP53 abnormalities, trisomy 12 and stereotyped subset #2 membership were equivalently associated with the shortest time-to-first-treatment and a treatment probability at five and ten years after diagnosis of 40% and 55%, respectively; the remaining cases exhibited 5-year and 10-year treatment probability of 12% and 25%, respectively. Within Binet A U-CLL patients, besides TP53 abnormalities, del(11q) and/or SF3B1 mutations were associated with the shortest time-to-first-treatment (5- and 10-year treatment probability: 78% and 98%, respectively); in the remaining cases, males had a significantly worse prognosis than females. In conclusion, the relative weight of indicators that can accurately risk stratify early-stage CLL patients differs depending on the somatic hypermutation status of the immunoglobulin heavy variable genes of each patient. This finding highlights the fact that compartmentalized approaches based on immunogenetic features are necessary to refine and tailor prognostication in CLL.
|
|
| 19. |
|
|
| 20. |
|
|
| 21. |
|
|
| 22. |
|
|
| 23. |
- Bernhardsson, Christian, et al.
(författare)
-
Radiological environmental monitoring at the ESS facility – Annual report 2020
- 2021
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- Results from the radiological environmental monitoring of the European Spallation Source (ESS) are presented for year 2020.Among the 63 environmental samples analysed for gamma emitting radionuclides, no elevated levels of anthropogenic radioactivity were observed. All samples (except two samples of lichen) had activity concentrations below the MDA for the natural radionuclides as well as 137Cs, and normal levels of 40K. In sewage sludge, detectable levels of 177Lu and 1311 were observed in samples that were measured within one week after sampling.Mobile gamma spectrometry surveys were carried out around ESS and MAX IV (when operating at high frequency during a test run). No deviating radiation levels were observed.The samples analysed for their 3H activity concentration (120 samples) were generally below the detection limit using the current procedure, instrumentation and analysis time (MDA typically 1.6 Bq L-1). The results show no evidence of any local contamination of 3H in Lund during 2020.The 14C data in the 26 samples of grass, fruits, berries, crops, milk, honey and meat of in the Lund area and in southern Sweden is consistent with the declining 14C specific activity in atmospheric CO2. Seasonal variations were observed in the 14C data. No evidence of anthropogenic 14C contamination in the Lund area was noted during 2020.The report presents the first base-line measurements of 129I (10 samples) in the ESS environmental monitoring programme. The 129I activity concentrations ranged between (3.18 ± 0.20)∙1011 atoms/kg d.w. for grass and (1.31 ± 0.03)∙1013 atoms/kg d.w. for moss. These values are in the expected range.
|
|
| 24. |
- Bernhardsson, Christian, et al.
(författare)
-
ZERO POINT ASSESSMENT OF THE RADIATION ENVIRONMENT – EXAMPLES OF A PROGRAM APPLIED IN SWEDEN (ESS) AND IN BELARUS (BELNPP)
- 2019
-
Ingår i: MEDICAL PHYSICS IN THE BALTIC STATES : Proceedings of the 14th International Conference on Medical Physics - Proceedings of the 14th International Conference on Medical Physics. ; , s. 85-88
-
Konferensbidrag (refereegranskat)abstract
- Before commissioning of a nuclear facility it is important to determine the baseline of the radiation environment. Such baseline or Zero Point assessments can only,and uniquely, be made before start of operation of the facility and will serve several purposes when the facility is in operation. Here we report on the planning and implementation of such a Zero Point program for achieving high reproducibility and effectiveness of the assessments around two nuclear installations.
|
|
| 25. |
- Bhoi, Sujata, et al.
(författare)
-
Prognostic impact of epigenetic classification in chronic lymphocytic leukemia : The case of subset #2
- 2016
-
Ingår i: Epigenetics. - : Informa UK Limited. - 1559-2294 .- 1559-2308. ; 11:6, s. 449-455
-
Tidskriftsartikel (refereegranskat)abstract
- Based on the methylation status of 5 single CpG sites, a novel epigenetic classification of chronic lymphocytic leukemia (CLL) was recently proposed, classifying CLL patients into 3 clinico-biological subgroups with different outcome, termed memory like CLL (m-CLL), naive like CLL (n-CLL), and a third intermediate CLL subgroup (i-CLL). While m-CLL and n-CLL patients at large corresponded to patients carrying mutated and unmutated IGHV genes, respectively, limited information exists regarding the less defined i-CLL group. Using pyrosequencing, we investigated the prognostic impact of the proposed 5 CpG signature in a well-characterized CLL cohort (135 cases), including IGHV-mutated and unmutated patients as well as clinically aggressive stereotyped subset #2 patients. Overall, we confirmed the signature's association with established prognostic markers. Moreover, in the presence of the IGHV mutational status, the epigenetic signature remained independently associated with both time-to-first-treatment and overall survival in multivariate analyses. As a prime finding, we observed that subset #2 patients were predominantly classified as i-CLL, probably reflecting their borderline IGHV mutational status (97-99% germline identity), though having a similarly poor prognosis as n-CLL patients. In summary, we validated the epigenetic classifier as an independent factor in CLL prognostication and provide further evidence that subset #2 is a member of the i-CLL group, hence supporting the existence of a third, intermediate epigenetic subgroup.
|
|
| 26. |
|
|
| 27. |
- Bohman, Mattias, et al.
(författare)
-
Biogas i Halland : Förbehandling av substrat och simulering av biogasflöden
- 2011
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- Bioenergicentrum i Halland (BEH) är ett projekt som ligger inom ramen för EU:s strukturfondsprogram. Projektet genomförs i Region Hallands regi som är regionens välfärds- och utvecklingsorganisation. Arbetet som bedrivs inom BEH syftar speciellt till att driva utvecklingen mot en ökad produktion och användning av bioenergi till biogas och i förlängningen fordonsgas. Genom att satsa på att skapa förutsättningar för innovation, kunskapsutveckling och samverkan främjas tillväxt och hållbar utveckling. Vid naturbruksgymnasiet i Plönninge utanför Halmstad finns idag en biogasanläggning som beskickas med bl.a. nötgödsel och matavfall. Dessutom finns en mindre pilotanläggning som är tänkt att fungera som en del av test- och verifieringsanläggning som BEH vill bygga upp i Plönninge. Som ett led i att utveckla dessa anläggningar och kunna erbjuda möjligheten till kunskapsinsamling genomfördes projektet som beskrivs i denna rapport. Uppdraget var att genomföra försöksrötningar på labb, använda resultaten för att skapa en modell som sedan kan nyttjas som ett verktyg i det inledande arbetet med att investera i en biogasanläggning som beskickas med lantbruksbaserade substrat. Högskolan i Halmstad (HH) genomförde försöksrötningarna och Grontmij (GM) använde sedan resultaten för att skapa en modell där bl.a. substrat, förbehandlingsteknik och driftkostnader finns med. Sammanfattningsvis kan sägas att majs som substrat fungerar bäst med de valda förbehandlingsmetoderna; kemisk behandling, termisk behandling och ultraljudsbehandling. Alla förbehandlingsmetoder med majs som substrat visade på ett positivt resultat, d.v.s. det ökade gasutbytet och dess värde (kr/kWh) översteg kostnaderna för de olika förbehandlingarna. Vad som måste beaktas är att produktionskostnaderna överlag är höga, med och utan förbehandling. Modellen har konstruerats på ett sådant sätt att den ska vara användarvänlig och med möjlighet att enkelt lägga till ytterligare substrat och förbehandlingsmetoder. Upprepningar av de försöksrötningar som genomförts kommer att öka tillförlitligheten hos modellen. Den fungerar som ett verktyg i att beräkna investeringsmarginalen för förbehandlingsutrustningen baserat på det valda substratet. På detta vis kan intressenter få en första indikation på om det är ekonomiskt rimligt att gå vidare med det tänkta substratet, den valda förbehandlingsmetoden, de planerade mängderna substrat etc. En investeringskalkyl har tagits fram för en gårdsanläggning som hanterar 5 000 ton substrat eller gödsel årligen. Det motsvarar 2-3 stycken medelstora mjölkgårdar. Kalkylen är översiktlig och syftar till att ge en första indikation på kostnader för de stora komponenterna såsom substratlager, rötkammare och rötrestlager. Kringarbeten såsom utredningar, markarbeten och geoundersökningar är inte med i kalkylen då dessa omkostnader till stor del avgörs av lokalisering och de förutsättningar som finns på platsen redan från start. Generellt kan dock sägas att den absolut billigaste och enklaste gårdsbaserade biogasanläggningen innebär en investering på 2,7-4 MSEK för flytgödsel från 100-300 mjölkkor. För BEH är det viktigt att skapa en plattform där intressenter kan komma för att genomföra försöksrötningar, byta erfarenheter och samla kunskap. För att uppnå detta är det nödvändigt att kunna erbjuda kunden kompletta och kompetenta lösningar på en och samma plats. Detta innebär ett erbjudande som innefattar försöksrötningar på labb-, pilot och fullskala. Ett förslag på konstruktion av pilotanläggning med övergripande principskiss ingår i denna rapport och fungerar som ett inledande arbete i projekteringen av en större pilotanläggning. Nödvändiga driftanalyser av rötrest ska kunna göras på plats i Plönninge på laboratoriet; analyser såsom enskilda organiska syror ska kunna skickas till lämpligt laboratorium. Personal ska kunna tillhandahållas för att driva och optimera rötningen enligt kundens syften och önskemål. På detta vis fungerar Region Halland som en länk mellan teori ochpraktik, mellan liten och stor skala och mellan aktörer från olika discipliner och geografiska områden.
|
|
| 28. |
|
|
| 29. |
|
|
| 30. |
- Boman, Mattias, et al.
(författare)
-
Moose Hunting Values in Sweden Now and Two Decades Ago : The Swedish Hunters Revisited
- 2011
-
Ingår i: Environmental and Resource Economics. - : Springer Science and Business Media LLC. - 0924-6460 .- 1573-1502. ; 50:4, s. 515-530
-
Tidskriftsartikel (refereegranskat)abstract
- This paper is based on two national contingent valuation studies dealing with the extent and economic values of hunting in Sweden. The first valuation study was conducted in 1987 and the second in 2006. Both the game resource and the hunter community have undergone changes in the two decades covered by the surveys. An important purpose of the latter survey was to repeat relevant parts of the former one, which created a rare opportunity to compare valuations covering a very long time span. Moose hunting value and its determinants were compared between the two studies, showing that significant changes have taken place. Our analysis suggests caution in using results from old contingent valuation studies for e.g. benefits transfer exercises.
|
|
| 31. |
- Boman, Mattias, et al.
(författare)
-
The hunting value of game in Sweden: Have changes occurred over recent decades?
- 2012
-
Ingår i: Scandinavian Journal of Forest Research. - : Informa UK Limited. - 0282-7581 .- 1651-1891. ; 27, s. 669-674
-
Tidskriftsartikel (refereegranskat)abstract
- This short communication deals with the hunting value of all game in Sweden, specifically changes over time in value and value components, and differences between the northern and southern parts of the country. The investigation was based on two mail surveys, one conducted in 1987 and the other in 2006. The results suggested that the gross hunting value and the hunting cost share of this value increased over the two decades. The consumer surplus (net value) share decreased correspondingly, while the recreation share and the meat share of the hunting value were more stable over time. It appeared that in 1987 as well as in 2006 the southern Swedish hunters tended to value their hunting higher than the hunters in northern Sweden, especially when it came to the recreation. The results should be relevant in the context of game management, adaptive game management in particular.
|
|
| 32. |
- Bridel, Claire, et al.
(författare)
-
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology : A Systematic Review and Meta-analysis
- 2019
-
Ingår i: JAMA Neurology. - : American Medical Association (AMA). - 2168-6149 .- 2168-6157. ; 76:9, s. 1035-1048
-
Forskningsöversikt (refereegranskat)abstract
- Importance Neurofilament light protein (NfL) is elevated in cerebrospinal fluid (CSF) of a number of neurological conditions compared with healthy controls (HC) and is a candidate biomarker for neuroaxonal damage. The influence of age and sex is largely unknown, and levels across neurological disorders have not been compared systematically to date.Objectives To assess the associations of age, sex, and diagnosis with NfL in CSF (cNfL) and to evaluate its potential in discriminating clinically similar conditions.Data Sources PubMed was searched for studies published between January 1, 2006, and January 1, 2016, reporting cNfL levels (using the search terms neurofilament light and cerebrospinal fluid) in neurological or psychiatric conditions and/or in HC.Study Selection Studies reporting NfL levels measured in lumbar CSF using a commercially available immunoassay, as well as age and sex.Data Extraction and Synthesis Individual-level data were requested from study authors. Generalized linear mixed-effects models were used to estimate the fixed effects of age, sex, and diagnosis on log-transformed NfL levels, with cohort of origin modeled as a random intercept.Main Outcome and Measure The cNfL levels adjusted for age and sex across diagnoses.Results Data were collected for 10 059 individuals (mean [SD] age, 59.7 [18.8] years; 54.1% female). Thirty-five diagnoses were identified, including inflammatory diseases of the central nervous system (n = 2795), dementias and predementia stages (n = 4284), parkinsonian disorders (n = 984), and HC (n = 1332). The cNfL was elevated compared with HC in a majority of neurological conditions studied. Highest levels were observed in cognitively impaired HIV-positive individuals (iHIV), amyotrophic lateral sclerosis, frontotemporal dementia (FTD), and Huntington disease. In 33.3% of diagnoses, including HC, multiple sclerosis, Alzheimer disease (AD), and Parkinson disease (PD), cNfL was higher in men than women. The cNfL increased with age in HC and a majority of neurological conditions, although the association was strongest in HC. The cNfL overlapped in most clinically similar diagnoses except for FTD and iHIV, which segregated from other dementias, and PD, which segregated from atypical parkinsonian syndromes.Conclusions and Relevance These data support the use of cNfL as a biomarker of neuroaxonal damage and indicate that age-specific and sex-specific (and in some cases disease-specific) reference values may be needed. The cNfL has potential to assist the differentiation of FTD from AD and PD from atypical parkinsonian syndromes.
|
|
| 33. |
- Brieghel, Christian, et al.
(författare)
-
Identifying patients with chronic lymphocytic leukemia without need of treatment : End of endless watch and wait?
- 2022
-
Ingår i: European Journal of Haematology. - : John Wiley & Sons. - 0902-4441 .- 1600-0609. ; 108:5, s. 369-378
-
Tidskriftsartikel (refereegranskat)abstract
- Introduction Early-stage chronic lymphocytic leukemia (CLL) challenges specialized management and follow-up.Methods We developed and validated a prognostic index to identify newly diagnosed patients without need of treatment (CLL-WONT) by a training/validation approach using data on 4708 patients. Composite scores derived from weighted hazards by multivariable analysis defined CLL-WONT risk groups.Results Age (>65 years: 1 point), Binet stage (B: 2 points), lactate dehydrogenase (LDH) (>205 U/L: 1 point), absolute lymphocyte count (15-30 x 10(9)/L: 1 point; >30 x 10(9)/L; 2 points), beta 2-microglobulin (>4 mg/L: 1 point), IGHV mutation status (unmutated: 1 point), and 11q or 17p deletion (1 point) were independently associated with shorter time to first treatment (TTFT). Low-risk patients demonstrated 5-year TTFT of 2% by internal validation, but 7-19% by external validation. Including all patients with complete scores, the 5-year TTFT was 10% for the 756 (39%) CLL-WONT low-risk patients, and the 704 (37%) patients who were both CLL-WONT and CLL-IPI low risk demonstrated even lower 5-year TTFT (8%).Conclusion We have adopted the CLL-WONT at an institution covering 1 800 000 individuals to allow patients with both low-risk CLL-WONT and CLL-IPI to be managed by primary healthcare providers, thereby prioritizing specialized hematology services for patients in dire need.
|
|
| 34. |
- Brieghel, Christian, et al.
(författare)
-
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome
- 2020
-
Ingår i: Clinical Cancer Research. - : AMER ASSOC CANCER RESEARCH. - 1078-0432 .- 1557-3265. ; 26:6, s. 1507-1515
-
Tidskriftsartikel (refereegranskat)abstract
- Purpose: Investigation of signaling pathways altered by recurrent gene mutations and their clinical impact in a consecutive cohort of patients with newly diagnosed chronic lymphocytic leukemia (CLL). The heterogeneous clinical course and genetic complexity of CLL warrant improved molecular prognostication. However, the prognostic value of recurrent mutations at the time of diagnosis remains unclear. Experimental Design: We sequenced samples from 314 consecutive, newly diagnosed patients with CLL to investigate the clinical impact of 56 recurrently mutated genes assessed by next-generation sequencing. Results: Mutations were identified in 70% of patients with enrichment among IGHV unmutated cases. With 6.5 years of follow-up, 15 mutated genes investigated at the time of diagnosis demonstrated significant impact on time to first treatment (TTFT). Carrying driver mutations was associated with shorter TTFT and poor overall survival. For outcome from CLL diagnosis, the number of signaling pathways altered by driver mutations stratified patients better than the number of driver mutations. Moreover, we demonstrated gradual impact on TTFT with increasing number of altered pathways independent of CLL-IPI risk. Thus, a 25-gene, pathway-based biomarker assessing recurrent mutations refines prognostication in CLL, in particular for CLL-IPI low- and intermediate-risk patients. External validation emphasized that a broad gene panel including low burden mutations was key for the biomarker based on altered pathways. Conclusions: We propose to include the number of pathways altered by driver mutations as a biomarker together with CLL-IPI in prospective studies of CLL from time of diagnosis for incorporation into clinical care and personalized follow-up and treatment.
|
|
| 35. |
- Brännvall, Rickard, et al.
(författare)
-
Data center excess heat recovery : A case study of apple drying
- 2020
-
Ingår i: ECOS 2020 - Proceedings of the 33rd International Conference on Efficiency, Cost, Optimization, Simulation and Environmental Impact of Energy Systems. - : ECOS 2020 Local Organizing Committee. ; , s. 2165-2174, s. 2165-2174
-
Konferensbidrag (refereegranskat)abstract
- Finding synergies between heat producing and heat consuming actors in an economy provides opportunity for more efficient energy utilization and reduction of overall power consumption. We propose to use low-grade heat recovered from data centers directly in food processing industries, for example for the drying of fruit and berries. This study analyses how the heat output of industrial IT-load on servers can dry apples in a small-scale experimental set up. To keep the temperatures of the server exhaust airflow near a desired set-point we use a model predictive controller (MPC) re-purposed to the drying experiment set-up from a previous work that used machine learning models for cluster thermal management. Thus, conditions with for example 37 C for 8 hours drying can be obtained with results very similar to conventional drying of apples. The proposed solution increases the value output of the electricity used in a data center by capturing and using the excess heat that would otherwise be exhausted. The results from our experiments show that drying foods with excess heat from data center is possible with potential of strengthening the food processing industry and contribute to food self-sufficiency in northern Sweden.
|
|
| 36. |
- Carlsson, Lars, et al.
(författare)
-
Adaptiv förvaltning
- 2010
-
Ingår i: Vilt, människa, samhälle. - Stockholm : Liber. - 9789147094189 ; , s. 227-239
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)
|
|
| 37. |
|
|
| 38. |
- Condoluci, Adalgisa, et al.
(författare)
-
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
- 2020
-
Ingår i: Blood. - : American Society of Hematology. - 0006-4971 .- 1528-0020. ; 135:21, s. 1859-1869
-
Tidskriftsartikel (refereegranskat)abstract
- Most patients with chronic lymphocytic leukemia (CLL) are diagnosed with early-stage disease and managed with active surveillance. The individual course of patients with early-stage CLL is heterogeneous, and their probability of needing treatment is hardly anticipated at diagnosis. We aimed at developing an international prognostic score to predict time to first treatment (TTFT) in patients with CLL with early, asymptomatic disease (International Prognostic Score for Early-stage CLL [IPS-E]). Individual patient data from 11 international cohorts of patients with early-stage CLL (n = 4933) were analyzed to build and validate the prognostic score. Three covariates were consistently and independently correlated with TTFT: unmutated immunoglobulin heavy variable gene (IGHV), absolute lymphocyte count higher than 15 x 10(9)/L, and presence of palpable lymph nodes. The IPS-E was the sum of the covariates (1 point each), and separated low-risk (score 0), intermediate-risk (score 1), and high-risk (score 2-3) patients showing a distinct TTFT. The score accuracy was validated in 9 cohorts staged by the Binet system and 1 cohort staged by the Rai system. The C-index was 0.74 in the training series and 0.70 in the aggregate of validation series. By meta-analysis of the training and validation cohorts, the 5-year cumulative risk for treatment start was 8.4%, 28.4%, and 61.2% among low-risk, intermediate-risk, and high-risk patients, respectively. The IPS-E is a simple and robust prognostic model that predicts the likelihood of treatment requirement in patients with early-stage CLL. The IPS-E can be useful in clinical management and in the design of early intervention clinical trials.
|
|
| 39. |
|
|
| 40. |
|
|
| 41. |
|
|
| 42. |
- Ericsson, Göran, et al.
(författare)
-
Viltet och människan
- 2010
-
Ingår i: Vilt, människa, samhälle. - 9789147094189 ; , s. 169-182
-
Bokkapitel (populärvet., debatt m.m.)
|
|
| 43. |
- Eriksson, Mattias, et al.
(författare)
-
Take-back agreements in the perspective of food waste generation at the supplier-retailer interface
- 2017
-
Ingår i: Resources, Conservation and Recycling. - : Elsevier. - 0921-3449 .- 1879-0658. ; 122, s. 83-93
-
Tidskriftsartikel (refereegranskat)abstract
- Food waste must be minimised to make food supply chains sustainable. This is especially relevant since food waste valorisation measures, such as energy recovery, have limited possibilities to fully recover the resources invested in food production. However, waste minimisation is costly when it includes new infrastructure or technology. Policy measures, on the other hand, can provide a low-cost option. Food rejection practices in supermarkets, such as take-back agreements (TBA), have long been identified as risk factors for food waste generation at the supplier-retailer interface, but given the relational, and often discreet, nature of these agreements, there is little evidence of their impact. In this study we provide, concrete evidence of different rejection practices. This is done by studying three types of food chains those for bread, fresh fruit and vegetables, and milk with different rejection practices in Sweden. Based on a combination of primary company information and stakeholder interviews, we found that a full TBA is in operation for bread. The retailer only pays for bread that is sold and any bread left unsold three days before the best-before date is returned to the supplier. For fresh fruit and vegetables, only goods of 'inadequate' quality are returned, but supermarkets have sole rights of determination on quality, posing a risk of categorising unsold fruit and vegetables as inadequate quality and returning them to suppliers. In the case of milk, suppliers take back unsold items, but only for waste management. The trend found in this study was that bread had the highest waste, and the most extensive take-back policy. Fresh fruit and vegetables had medium levels of waste, partly due to unverified rejections, while milk had a very low level of waste combined with an even lower level of rejections. It can be concluded that a food supply chain system where the direct costs of waste management or incentives for waste reduction are separated from the organisation responsible for generating the waste poses a significant risk factor in food waste generation and is therefore a potential hotspot for waste-reducing measures. (C) 2017 Elsevier B.V. All rights reserved.
|
|
| 44. |
- Eriksson Stenström, Kristina, et al.
(författare)
-
Identifying radiologically important ESS-specific radionuclides and relevant detection methods
- 2020
-
Bok (refereegranskat)abstract
- The European Spallation Source (ESS) is under construction in the outskirts of Lund in southern Sweden. When ESS has entered the operational phase in a few years, an intense beam of high-energy protons will not only produce the desired spallation neutrons from a large target of tungsten, but a substantial number of different radioactive by-products will also be generated. A small part of these will be released to the environment during normal operation. During an accident scenario, a wide range of gases and aerosols may be released from the tungsten target. The palette of radionuclides generated in the ESS target will differ from that of e.g. medical cyclotrons or nuclear power plants, thus presenting new challenges e.g. in the required environmental monitoring to ensure that dose limits to the public are not exceeded. This project (SSM2018-1636), financed by the Swedish Radiation Safety Authority (SSM), aimed to strengthen competence at Lund University for measurement and analysis of ESS-specific radionuclides. First, an extensive literature review, including modelling as well as experimental analyses, of ESS-relevant radionuclides was performed. We found that radionuclide production in particle accelerators is well-known, while experience with tungsten targets is very limited. As a second part of the project, an independent simplified model of the ESS target sector for the calculations of radionuclide production in the ESS tungsten target was developed using the FLUKA code. We conclude that we have a fairly good agreement with results of other authors, except for 148Gd, and that the calculated radionuclide composition is sensitive to the nuclear interaction models used.In the third part of the project, known environmental measurement technologies for various ESS-relevant radionuclides were reviewed, focussing on pure difficult-to-measure alpha- and beta-emitters. Liquid scintillation counting (LSC) is a suitable technique e.g. for the important beta emitters 3H, 14C, 35S, 31P and 33P. Several ESS radionuclides of relevance for dose estimates have never been investigated by environmental analytical techniques, due to their absence in the normal environment. Alpha spectrometry seems promising for the analysis of alpha-emitting lanthanides, in particular for 148Gd. Among the many types of mass spectrometry techniques, ICP-MS (inductively coupled plasma mass spectrometry) and AMS (accelerator mass spectrometry) seem to be the most suitable for the analysis of long-lived ESS radionuclides in environmental samples (e.g. 243Am and possibly lanthanides for ICP-MS and 10Be, 14C, 32Si, 36Cl, 60Fe and 129I for AMS).Three experimental parts were performed during the project, related to initiation of radioactivity measurements of aerosols at Lund University, mapping of environmental tritium in the Lund area, and establishment of a method to measure tritium in urine followed by a study of tritium in persons presently living or working in Lund. Aerosols were collected at a rural background station (Hyltemossa near Perstorp, northern Skåne) using a high-volume aerosol sampler with automatic filter change (DHA-80, Digitel). Gamma spectrometry measurements of 7Be agreed rather well with results from a nearby air monitoring station (SSM/FOI). Tritium (radioactive hydrogen) is expected to dominate the source term from the ESS target station to the environment. We have performed several investigations to monitor the current situation of tritium in Lund using LSC: the matrices investigated included air humidity, precipitation, pond water, indoor air at one accelerator facility and urine from the general public as well as from persons who may be occupationally exposed to tritium. Environmental tritium was generally very low (<3.4 Bq L-1), with somewhat higher concentration in the springtime than during the rest of the year. Tritium in the vast majority of the 55 urine samples was also very low: only a few exposed workers were found to have up to 11 Bq L-1 in their urine, which still is very low compared to e.g. reactor workers. Suggestions for further actions and work related to measurement and analysis of ESS relevant radionuclides are presented.
|
|
| 45. |
- Ezebilo, Eugene Ejike, et al.
(författare)
-
Preferences and willingness to pay for close to home nature for outdoor recreation in Sweden
- 2015
-
Ingår i: Journal of Environmental Planning and Management. - : Informa UK Limited. - 0964-0568 .- 1360-0559. ; 58, s. 283-296
-
Tidskriftsartikel (refereegranskat)abstract
- In Sweden there is a strong tradition of using nature areas for outdoor recreation. This paper reports on a study which explored preferences and willingness to pay for outdoor recreation close to home (<= 100km away from home and <= 24hours stay at a recreation site) using the contingent valuation method. The data originated from a mail survey that involved Swedish residents who were randomly selected from a national register. An ordinary least squares regression model was used to account for factors influencing willingness to pay. The results showed that approximately 50% of the respondents used nature areas close to their home for recreation and their average frequency of visits to these areas was 74times annually. Areas dominated by forests were the most preferred, followed by water. The respondents were willing to pay approximately 7200 SEK (US$1080) annually. Their willingness to pay was influenced by factors such as type of nature area, distance to and time spent at the recreation site and income. The results provide one input to the land use planning process by considering the demand for nature-based outdoor recreation close to home.
|
|
| 46. |
|
|
| 47. |
- Fredman, Peter, et al.
(författare)
-
Economic values in the Swedish nature-based recreation sector : a synthesis
- 2012
-
Ingår i: Tourism Economics. - London : IP Publishing. - 1354-8166 .- 2044-0375. ; 18:4, s. 903-910
-
Forskningsöversikt (refereegranskat)abstract
- This research synthesis reports the main findings from a review of economic values associated with nature-based recreation in Sweden. The purpose of the work was to support policy and to identify areas for future research. Data came from over 150 scientific publications and other public sources. The authors find inter alia a lack of systematic data for several recreation activities (including naturebased tourism), a significant growth in the outdoor equipment industry and a relatively modest economic involvement by the public sector. The information is structured under different categories to illustrate the significance and range of different economic values. The authors conclude that there is a need for more comprehensive and systematically collected data, methodological development and interdisciplinary research.
|
|
| 48. |
|
|
| 49. |
- Grootens, Jennine, et al.
(författare)
-
Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis
- 2019
-
Ingår i: EBioMedicine. - : ELSEVIER SCIENCE BV. - 2352-3964. ; 43, s. 150-158
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Systemic mastocytosis (SM) is a haematological disease characterised by organ infiltration by neoplastic mast cells. Almost all SM patients have a mutation in the gene encoding the tyrosine kinase receptor KIT causing a D816V substitution and autoactivation of the receptor. Mast cells and CD34(+) haematopoietic progenitors can carry the mutation: however, in which progenitor cell subset the mutation arises is unknown. We aimed to investigate the distribution of the D816V mutation in single mast cells and single haematopoietic stem and progenitor cells.Methods: Fluorescence-activated single-cell index sorting and KIT D816V mutation assessment were applied to analyse mast cells and >10,000 CD34(+) bone marrow progenitors across 10 haematopoietic progenitor subsets. In vitro assays verified cell-forming potential.Findings: We found that in SM 60-99% of the mast cells harboured the KIT D816V mutation. Despite increased frequencies of mast cells in SM patients compared with control subjects, the haematopoietic progenitor subset frequencies were comparable. Nevertheless, the mutation could be detected throughout the haematopoietic landscape of SM patients, from haematopoietic stem cells to more lineage-primed progenitors. In addition, we demonstrate that Fc epsilon RI+ bone marrow progenitors exhibit mast cell-forming potential, and we describe aberrant CD45RA expression on SM mast cells for the first time.Interpretation: The KIT D816V mutation arises in early haematopoietic stem and progenitor cells and the mutation frequency is approaching 100% in mature mast cells, which express the aberrant marker CD45RA.
|
|
| 50. |
|
|
